Antreol (Anastrozole)

Medicine Overview

Antreol (Anastrozole) is an aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen production, helping to slow or stop cancer cell growth. Antreol is often prescribed as part of adjuvant therapy following surgery or as a first-line treatment in advanced stages. Its once-daily oral dosage makes it convenient for long-term use. Antreol is clinically proven to reduce recurrence risk and improve survival rates in eligible patients.